No insider purchase over the last 90 days. The latest was filed 17 Oct 2024.
Follow the Upstream Bio, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €366.4m. The latest transaction was disclosed on 17 September 2026 (Cession). Among the most active insiders: Ambrose Allison. All data is openly available.
21
Insider Decl.
n/a
Thresholds
€18M
1 ops.
Buy Volume
€64,656
12 ops.
Sell Volume
48Σ signal
Buys €18M€64,656 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Upstream Bio, Inc. is a company listed on the XNAS market, focused on developing innovative biological therapies. It aims to provide solutions for immunological and inflammatory diseases.